Qiagen NV (WBO:QGE2)
€ 43.02 0.09 (0.21%) Market Cap: 9.55 Bil Enterprise Value: 9.97 Bil PE Ratio: 110.35 PB Ratio: 2.83 GF Score: 85/100

Qiagen NV at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2022 / 02:30PM GMT
Release Date Price: €47.71 (-0.19%)
Unidentified Analyst

So welcome, everyone, and a warm welcome to our fireside chat today hosted by the MS Global Healthcare Conference. I'm [Aisha Noor] from the European MedTech team here at Morgan Stanley, and I'm very pleased to be joined today by Thierry Bernard, CEO of QIAGEN. This session will take approximately 30 minutes, and you can participate with your questions for this session by just raising your hand, and I'll let you speak. With that, welcome Thierry, and thank you for joining us today.

Questions & Answers

Unidentified Analyst

Maybe if we start off with your 5 pillars of growth, starting off with sample tech. I mean, growth in your sample tech business, especially even in the non-COVID segment, was relatively strong in the first half. How much of that would you attribute to market recovery versus market share gains? And how sustainable do you think that is going forward?

Thierry Bernard
Qiagen N.V. - CEO, MD & Member of Management Board

Thanks, and thanks for your attention and for coming this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot